Article Details
Retrieved on: 2022-01-06 10:33:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New data with PureTech's LYT-100, a rival to Roche's Esbriet for idiopathic pulmonary fibrosis, suggests it is less likely to cause ...
Article found on: pharmaphorum.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here